NO992244L - AIDS-legemiddel - Google Patents

AIDS-legemiddel

Info

Publication number
NO992244L
NO992244L NO992244A NO992244A NO992244L NO 992244 L NO992244 L NO 992244L NO 992244 A NO992244 A NO 992244A NO 992244 A NO992244 A NO 992244A NO 992244 L NO992244 L NO 992244L
Authority
NO
Norway
Prior art keywords
kni
active ingredient
inhibitory activity
auxiliary effect
drug
Prior art date
Application number
NO992244A
Other languages
English (en)
Other versions
NO992244D0 (no
Inventor
Hideharu Sato
Makoto Shintani
Tominaga Fukazawa
Akihiro Muto
Keisuke Terajima
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO992244D0 publication Critical patent/NO992244D0/no
Publication of NO992244L publication Critical patent/NO992244L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Et medisinsk preparat som er egnet for tilførsel av et medikament med HIV-proteaseinhiberende aktivitet slik at det oppnås en høyere hjelpevirkning. Preparatet er et AIDS-middel som omfatter KNI-272 og minst en for- bindelse, som den essensielle, aktive bestanddel med inhiberende aktivitet overfor en protease fra humant immun- defisiensvirus, utvalgt fra gruppen som består av forbindelsene som generelt betegnes Saquinavir, Ritonavir, Indinavir og Nelfinavir. KNI-272 og den aktive bestanddel inngår i et mengde- forhold og i mengder som gir en syner- gistisk hjelpevirkning.
NO992244A 1996-11-08 1999-05-07 AIDS-legemiddel NO992244L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP31277296 1996-11-08
JP34455096 1996-12-09
JP29336597 1997-10-09
PCT/JP1997/004057 WO1998020888A1 (fr) 1996-11-08 1997-11-07 Medicament contre le sida

Publications (2)

Publication Number Publication Date
NO992244D0 NO992244D0 (no) 1999-05-07
NO992244L true NO992244L (no) 1999-07-07

Family

ID=27337810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992244A NO992244L (no) 1996-11-08 1999-05-07 AIDS-legemiddel

Country Status (6)

Country Link
US (1) US20020068749A1 (no)
EP (1) EP0955054A4 (no)
AU (1) AU716760B2 (no)
CA (1) CA2270546A1 (no)
NO (1) NO992244L (no)
WO (1) WO1998020888A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2336134T (pt) 1998-06-23 2016-10-19 The Board Of Trustees Of The Univ Of Illionis Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
US6448245B1 (en) 2000-05-04 2002-09-10 The United States Of America As Represented By The Department Of Health And Human Services Methods of and compounds for inhibiting calpains

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
IL114808A (en) * 1994-08-11 1999-10-28 Merck & Co Inc Combinations of protease inhibitors for the treatment of hiv infection and aids
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US5750493A (en) * 1995-08-30 1998-05-12 Raymond F. Schinazi Method to improve the biological and antiviral activity of protease inhibitors
EP0878194A1 (en) * 1996-01-31 1998-11-18 Sankyo Company Limited Remedies or preventives for aids

Also Published As

Publication number Publication date
US20020068749A1 (en) 2002-06-06
CA2270546A1 (en) 1998-05-22
WO1998020888A1 (fr) 1998-05-22
AU716760B2 (en) 2000-03-09
NO992244D0 (no) 1999-05-07
EP0955054A1 (en) 1999-11-10
EP0955054A4 (en) 2003-01-29
AU4885397A (en) 1998-06-03

Similar Documents

Publication Publication Date Title
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
DK1207756T3 (da) Anvendelse af spinosad eller en formulering, der omfatter spinosad
SE8804629D0 (sv) New therapeutically active compounds
NO20100569L (no) Farmasoytiske formuleringer og anvendelse derav i forebyggelsen av slag, diabetes og/eller kongestivt hjertesvikt
PT951474E (pt) Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
EP1340744A3 (en) Hiv protease inhibitors
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
OA12806A (en) Novel perindopril salt and pharmaceutical compositions containing same.
WO2006044968A3 (en) Combination therapy for treating viral infections
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
BG105173A (en) Novel salt form of pantoprazole
EP1213026A4 (en) AGENTS CONTAINING GINSENG FOR PROTECTING CEREBRAL CELLS OR NERVOUS CELLS
TNSN02039A1 (en) RECONSTITUTABLE PARENTERAL COMPOSITION
HUP0400553A2 (hu) Gyógyászati készítmények
DE50109650D1 (de) Topische behandlung bei der mastalgie
PH27446A (en) Compound with gastric acid inhibitory effect
NO992244L (no) AIDS-legemiddel
AU5158000A (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
DK1007034T3 (da) Præparater indeholdende Bergamottin til forøgelse af den orale biotilgængelighed af farmaceutiske midler
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
GB1493237A (en) Pharmaceutical preparations for the treatment of hyperuricacidemia
JPH02233616A (ja) 低用量ベナゼプリル／チアジド利尿薬組成物
ECSP055804A (es) Composición farmacéutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application